To clarify magnesiummetabolism in thyroid dysfunction, plasma and erythrocyte magnesiumconcentrations (P-Mg, E-Mg) were determined in patients with untreated thyroid diseases and their relations to thyroid hormone levels and the duration of illness were examined. P-Mgwas significantly lower in hyperthyroid patients than in euthyroid or hypothyroid individuals. E-Mg was significantly higher in hypothyroid patients than in hyperthyroid or euthyroid individuals. In the entire series of 84 subjects, both P-Mgand E-Mgshowed significant negative correlations with thyroid hormonelevels, but the correlations were greater in P-Mg than E-Mg. In hyperthyroid patients, both P-Mg and E-Mg were negatively correlated with the duration of illness, but this correlation was greater in E-Mg than P-Mg. Also, both P-Mg and E-Mg were significantly higher in patients with destructive thyroiditis with a short duration (0.5 months) such as subacute or painless thyroiditis than in patients with Graves' disease (4.9 months). These results suggest that magnesium metabolism in thyroid dysfunction is affected not only by thyroid hormone levels but also by the duration of illness.
Magnesiummetabolism is knownto be related to thyroid function. Improvements in clinical symptoms in hyperthyroid patients after administration of magnesium (1 , 2) and reduction in thyroid function and enlargement of the thyroid gland in rats fed a magnesium-deficient diet (3, 4) have been reported. However, there is as yet no consensus about the effects of thyroid hormone on magnesium metabolism. Plasma magnesiumconcentration was reportedly reduced in hyperthyroid patients and increased in hypothyroid patients in many studies (5-9), but was not different as compared with normal subjects in some studies (10, ll) . On the other hand, reports concerning erythrocyte magnesium concentration are few (6-9), and its relation to thyroid function remains to unclear.
In this study, we examined plasma and erythrocyte magnesium concentrations (P-Mg, E-Mg) in patients with untreated thyroid diseases, and their relations to thyroid hormone levels and the duration of illness to clarify magnesiummetabolism in thyroid dysfunction.
SUBJECTS AND METHODS
The subjects consisted of 84 patients (13 males and 71 females) who were treated at the Thyroid Clinic, Internal Department, Hyogo Prefectural Amagasaki Hospital for the first time. The diagnoses were madeon the basis of the history of present illness, physical examination, blood hormone levels, Magnesiumin Thyroid Disease with hypertension, diabetes mellitus, liver disease, or renal disease were excluded from this study. Table  1 shows the diseases and the number of patients with them in the 26 euthyroid, 45 hyperthyroid, and 13 hypothyroid subjects.
Blood was drawn between 9 and 10 a.m. after an overnight fast. Serum was isolated from a part of the blood, and the remaining blood was centrifuged with 5 mMEDTA-2Kduring refrigeration to separate plasma from erythrocytes. The erythrocyte were washed three times with isotonic choline chloride during refrigeration, as described previously (12) . The serum, plasma, and erythrocytes samples were stored at -20°C until measurement. Magnesiumconcentration was determined by atomic absorption spectrophotometry (Model AA-1;
Nippon Jarrell-Ash, Co., Ltd, Kyoto, Japan), and P-Mg was expressed as mmol/1 and E-Mgas mmol/1 packed cell.
Triiodothyronine (T3), thyroxine (T4), and free thyroxine (Free T4) were determined by radioimmunoassay, and thyroid-stimulating hormone (TSH) by fluoroimmunoassay using commercially available kits. Table 2 summarizes the results of the thyroid function tests in the euthyroid, hyperthyroid, and hypothyroid patients.
All values were expressed as means ± SD.
Student's t-test was performed whenthe results of analysis of variance by one-way layout were significant, p-values of less than 0.05 were regarded as statistically significant. Table 3 shows the mean values of age, anthropometric measurements, and serum albumin and creatinine levels in euthyroid, hyperthyroid, and hypothyroid patients. The age was slightly higher in the hypothyroid group, but the difference was not significant. There were no significant differences in body height or weight among the three groups.
RESULTS
Serum albumin level of hyperthyroid patients was significantly lower than that of euthyroid or hypothyroid patients, and serum creatinine level was reduced in hyperthyroid patients but increased in hypothyroid patients, each group showing a significant difference as compared with the euthyroid group. Figure 1 shows the meanvalues of P-Mgand E-Mg in euthyroid, hyperthyroid, and hypothyroid patients. P-Mg was significantly lower in the hyperthyroid group than in the euthyroid or hypothyroid group. Also, it was significantly higher in the hypothyroid group than in the euthyroid group. Since serum albumin level was significantly reduced in hyperthyroid patients, correction of the values was made according to the formula of Kroll and Elin (13). P-Mg for the hyperthyroid group was 0.77 ± 0.05, as compared to 0.73 ± 0.06 mmol/1 before correction. The differences in P-Mg were statistically significant even after correction. E-Mg showed a similar tendency to P-Mg, and was significantly higher in the hypothyroid group than in the euthyroid or hyperthyroid group.
In the entire group of 84 subjects, P-Mg showed significant negative correlations with T3
(r=-0.669), T4 (r=-0.683), and Free T4 (r = -0.710) (Fig. 2) . E-Mg also showed significant negative correlations with T3 (r=-0.299), T4 (r=-0.270), and Free T4 (r=-0.288) ( centrations with thyroid hormone levels and the duration of illness was studied next in 45 hyperthyroid patients. In this study, the interval between the appearance of clinical symptomsand the first examination was regarded as the duration of disease. As shown in Table 4 , both P-Mg and E-Mg were negatively correlated with not only thyroid hormone levels but also the duration of illness. P-Mg had greater correlations with thyroid hormone levels than with the duration of illness, whereas E-Mgshowed greater correlations with the duration of illness than with the hormone levels. Between the group with Graves' disease and the group with destructive thyroiditis such as subacute or painless thyroiditis, thyroid hormone levels were slightly higher in the first group, but the difference was not significant. However, the duration of illness was 4.9 months for Graves' disease and 0.5 months for destructive thyroiditis, and both P-Mg and E-Mg were significantly higher in the destructive thyroiditis group than in the Graves' disease group (Table 5) .
DISCUSSION
Abnormalplasma magnesiumlevels are often observed in thyroid diseases, but it is considered to be secondary to thyroid dysfunction rather than specific to the disease themselves. There have been a number of reports that plasma magnesiumconcentration was reduced in hyperthyroidism but elevated in hypothyroidism (5-9). Moreover, plasmamagnesiumconcentration is reported to be normalized as thyroid function is improved by treatment. Some authors, however, observed no difference in plasma magnesium concentration in hyperthyroid or hypothyroid patients as compared with normal controls (10, 1 1). These discrepancies amongthe reports maybe ascribed to the unavailability of atomic absorption spectrophotometry for determination of magnesiumconcentration or the inaccuracy of evaluation of thyroid function because of the absence of radioimmunoassay in all these studies, which were performed more than 20 years ago. Recently, Dolev et al. (14) reported that a significant negative correlation was found between plasma magnesiumconcentration and thyroxine, seemingly suggesting that hyperthyroid patients have a lower plasma magnesiumlevel than normal subjects, but that the difference between the two groups disappeared whenthe magnesiumlevel was corrected for serum albumin. Since hyperthyroidism is often accompanied by hypoalbuminemia, they suggested the possibility that hypoalbuminemia is involved in the hypomagnesemia observed in hyperthyroid patients. In this study, plasma magnesiumconcentration showed a significant negative correlation with thyroid hormone levels, and was significantly lower in hyperthyroid patients but significantly higher in hypothyroid patients than in euthyroid controls. Wecorrected the magnesiumconcentration using the formula of Kroll and Elin (13) to eliminate the effect of serum albumin level, but similar significant differences were observed also after correction. Therefore, the changes in plasma magnesiumconcentration in patients with thyroid dysfunction cannot be regarded simply as a result of changes in serum albumin level. On the other hand, it is generally agreed that thyroid hormones increase urinary excretion of magnesium.It has been reported that an increase in glomerular filtration rate (8, 15) or in urinary calcium excretion (16) Urinary magnesiumexcretion is knownto increase and serum magnesiumconcentration to decrease under conditions that the renin-aldosterone system is activated (19, 20) . Wuttke and Kessler (21) suggested increase secretion of aldosterone in hyperthyroidism on the basis of the finding that the reduced magnesium concentration in hyperthyroid patients was improved by administration of spinorolactone.
There have been few studies of erythrocyte magnesiumconcentration in thyroid diseases, and the findings have not been consistent. Zumkley (9) reported that erythrocyte magnesiumconcentration was reduced in hyperthyroidism or elevated in hypothyroidism as compared with normal controls.
Several reports, however, showed no difference in erythrocyte magnesiumconcentration amongthe three groups (6-8). Moreover, a recent study by Dolev et al. (14) denied the presence of a significant correlation betweenerythrocyte magnesium concentration and thyroid hormone levels. In this study, erythrocyte magnesium concentration wassignificantly higher in hypothyroid subjects than in euthyroid or hyperthyroid subjects. In the entire group of subjects, erythrocyte magnesium concentration showed significant negative correlations with thyroid hormone levels, though they were not as great as the correlations of plasma magnesium concentration. Wefurther studied the relationships of blood magnesiumconcentrations with thyroid hormone levels and the duration of illness in 45 hyperthyroid patients. Interestingly, plasma magnesium concentration showeda significant negative correlation with thyroid hormone levels rather than the duration of illness, whereas erythrocyte magnesium concentration showeda significant negative correlation with the duration of illness rather than the hormone levels. Since a significant positive correlation was found between erythrocyte and plasma magnesium concentration, the change in erythrocyte magnesium concentration is considered to be secondary to that in plasma concentration.
However, the life span of erythrocyte may be involved in the relationship between erythrocyte magnesiumconcentration and the duration of illness. Considering the report that the life span of erythrocyte is reduced in hyperthyroidism (22), erythrocyte magnesiumconcentration maybe altered with the duration of illness. Moreover, erythrocyte magnesiumconcentration is reported to be elevated with an increase in the activity of erythrocyte membrane Na-K ATPase (23, 24) . In hyperthyroidism, protein degradation is promoted by excess thyroid hormones, and the amount of Na-K ATPase in the erythrocyte membrane is reduced (25, 26) . However, the amount of Na-K ATPasein the erythrocyte membrane was shownnot to be changed by short incubation with thyroid hormone, and the reduction in the amount of Na-KATPasein the erythrocyte membraneis considered to be affected by the extent and the duration of the excess in thyroid hormones (27).
These results suggested that plasma magnesium concentration is reduced in hyperthyroidism, but that the reduction in erythrocyte magnesiumconcentration is brought about by excessive secretion of thyroid hormones for a certain period. Therefore, magnesium metabolism in thyroid dysfunction is considered to be affected not only by the thyroid hormone levels but also by the duration of illness. Plasma and erythrocyte magnesiumconcentration may be useful as indices, respectively, of the state of thyroid hormone secretion and its duration. Aldosterone and plasma renin activity in hyperthyroid rats: Effects of propranolol and propylthiouracil. J
